Maze Therapeutics, Inc. Common Stock (MAZE) support and resistance · $525.3M cap
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
This page maps Maze Therapeutics, Inc. Common Stock (MAZE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
MAZE currently screens at market cap $525.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MAZE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MAZE quote page for the session range and the stock page for the full model.
Not investment advice.